Literature DB >> 21649568

Hepatic artery thrombosis after orthotopic liver transplant: a review of the same institute 5 years later.

Linwei Wu1, Jianwei Zhang, Zhiyong Guo, Qiang Tai, Xiaoshun He, Weiqiang Ju, Dongping Wang, Xiaofeng Zhu, Yi Ma, Guodong Wang, Anbin Hu.   

Abstract

OBJECTIVES: Summarize the experience of managing patients with hepatic artery thrombosis after orthotopic liver transplant in a single center.
MATERIALS AND METHODS: A total of 726 adult patients who received a liver transplant at the Department of Organ Transplantation, the First Affiliated Hospital of Sun Yat-Sen University, between January 2004 and December 2009, were selected. Fourteen patients had hepatic artery thrombosis after the operation, and the clinical data of these patients were analyzed retrospectively.
RESULTS: The incidence rate of hepatic artery thrombosis was 1.9% (14/726), and the mean time of onset was 10 days (range, 1-41 d) after surgery. Six patients had acute deterioration of liver function, 4 had bile leakage, 1 had hepatic abscess, and 3 had no symptoms. Three patients received urgent rearterialization, 2 received intra-arterial thrombolysis, 3 received combined urgent rearterialization and intra-arterial thrombolysis, and 6 patients received a retransplant. The mortality rate associated with hepatic artery thrombosis was 42.9% (6/14); 2 from biliary necrosis and secondary hepatic failure after urgent rearterialization; 1 from recurrent hepatic artery thrombosis and multiple organ failure after intra-arterial thrombolysis; 1 from renal failure and severe infection after combined urgent rearterialization and intra-arterial thrombolysis, and 2 from severe infection after retransplant. The other patients recovered and were followed for 18 to 66 months. Their liver grafts all functioned well with a patent artery. Two died from tumor recurrence at 18 and 29 months after transplant.
CONCLUSIONS: Hepatic artery thrombosis is a severe complication after liver transplant, which leads to graft loss and recipient death. Rearterialization as early as possible before irreversible biliary and liver parenchyma damage can avoid retransplant.

Entities:  

Mesh:

Year:  2011        PMID: 21649568

Source DB:  PubMed          Journal:  Exp Clin Transplant        ISSN: 1304-0855            Impact factor:   0.945


  7 in total

1.  Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients.

Authors:  Jonathan G Stine; Shawn J Pelletier; Timothy M Schmitt; Robert J Porte; Patrick G Northup
Journal:  HPB (Oxford)       Date:  2015-12-10       Impact factor: 3.647

2.  Biliary Complication in Pediatric Liver Transplantation: a Single-Center 15-Year Experience.

Authors:  Chih-Yang Hsiao; Cheng-Maw Ho; Yao-Ming Wu; Ming-Chih Ho; Rey-Heng Hu; Po-Huang Lee
Journal:  J Gastrointest Surg       Date:  2019-01-10       Impact factor: 3.452

Review 3.  Intraoperative Doppler Ultrasound for Detection of Early Postoperative Vascular Complications in Orthotopic Liver Transplants.

Authors:  Raymond I Okeke; Jeffery Bettag; Reeder Wells; Michaela Wycoff; Taylor Hallcox; Justin Lok; Alexandra Phocas; David L Annakie; Ramy Shoela; Mustafa Nazzal
Journal:  Cureus       Date:  2022-06-19

Review 4.  Management of early hepatic artery occlusion after liver transplantation with failed rescue.

Authors:  Chih-Yang Hsiao; Cheng-Maw Ho; Yao-Ming Wu; Ming-Chih Ho; Rey-Heng Hu; Po-Huang Lee
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

5.  Re-transplantation for Hepatic Artery Thrombosis: A National Perspective.

Authors:  Shu Kwun Lui; Catherine R Garcia; Xiaonan Mei; Roberto Gedaly
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

6.  Impact of ABO-incompatibility on hepatic artery thrombosis in living donor liver transplantation.

Authors:  Seong Hoon Kim; Jangho Park; Sang Jae Park
Journal:  Ann Transl Med       Date:  2019-11

7.  Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation.

Authors:  Johannes Dillmann; Felix C Popp; Barbara Fillenberg; Florian Zeman; Elke Eggenhofer; Stefan Farkas; Marcus N Scherer; Michael Koller; Edward K Geissler; Robert Deans; Deborah Ladenheim; Martin Loss; Hans J Schlitt; Marc H Dahlke
Journal:  Trials       Date:  2012-11-15       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.